2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $29M | $45M | $55M | $44M | $39M |
Cost of Revenue | $0 | $0 | $0 | -$441K | $0 |
Gross Profit | $29M | $45M | $55M | $44M | $39M |
Gross Profit % | 100% | 100% | 100% | 101% | 100% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$32M | -$36M | $2.4M | -$7.4M | -$12M |
Dep. & Amort. | $1.9M | $2.3M | $2.7M | $2.9M | $3.1M |
Def. Tax | -$6.4M | $8.7M | $0 | $0 | $0 |
Stock Comp. | $0 | $1.3M | $1.8M | $3.8M | $4.1M |
Chg. in WC | $1.4M | $2.7M | -$3.5M | -$14M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $316M | $193M | $41M | $46M | $43M |
ST Investments | $245M | $325M | $314M | $284M | $0 |
Cash & ST Inv. | $561M | $518M | $355M | $46M | $43M |
Receivables | $5.7M | $5.4M | $1.5B | $0 | $0 |
Inventory | -$328M | -$199M | $1.4B | $0 | $0 |
Achieved 3% loan growth and $44 million in deposit growth in Q1, with a 27 basis point expansion in net interest margin and a 15 basis point improvement in loan yield.
Reported a net loss of $2.7 million (or $0.13 per diluted share) for the quarter, but increased tangible book value per share to $14.81, aided by repurchasing 464,000 shares at a discount to book value.
Loan production totaled $90 million at a weighted average yield of ~7.1%, including $33 million in commercial real estate, $9 million in residential mortgages, $7 million in construction loans, and $35 million in purchased credit-enhanced consumer loans.
Core deposits grew by 3.8%, with strategic focus on deepening commercial relationships; cost of deposits declined by 14 basis points, and brokered deposits were used to extend duration at lower rates.
Forward outlook: Expect further net interest margin expansion of 5–10 basis points in Q2; operating expenses projected in the high $13 million to low $14 million range; continued share buybacks anticipated, with additional margin expansion likely in early 2026 as lower-yielding multifamily loans reprice.